EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Specific associations between plasma biomarkers and postmortem amyloid plaque and tau tangle loads

Gemma Salvadó iD, Rik Ossenkoppele iD, Nicholas J Ashton iD, Thomas G Beach, Geidy E Serrano, Eric M Reiman, Henrik Zetterberg, Niklas Mattsson-Carlgren iD, Shorena Janelidze, Kaj Blennow iD, Oskar Hansson iD

EMBO Molecular Medicine · 08.05.2023 · 15 (5)

DOI: 10.15252/emmm.202217123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift EMBO Molecular Medicine, online erschienen am 13.03.2023. Verfasst von Gemma Salvadó und 10 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Memory Research Unit, Department of Clinical Sciences, Malmö, Lund University, Lund, Sweden. Hauptthemen laut MEDLINE: Plaque, Amyloid, Alzheimer Disease. Die Arbeit wurde bisher 215-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, NIA NIH HHS, AD Strategic Fund and Alzheimer's Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Several promising plasma biomarkers for Alzheimer's disease have been recently developed, but their neuropathological correlates have not yet been fully determined. To investigate and compare independent associations between multiple plasma biomarkers (p‐tau181, p‐tau217, p‐tau231, Aβ42/40, GFAP, and NfL) and neuropathologic measures of amyloid and tau, we included 105 participants from the Arizona Study of Aging and Neurodegenerative Disorders (AZSAND) with antemortem plasma samples and a postmortem neuropathological exam, 48 of whom had longitudinal p‐tau217 and p‐tau181. When simultaneously including plaque and tangle loads, the Aβ42/40 ratio and p‐tau231 were only associated with plaques (ρ Aβ42/40 [95%CI] = −0.53[−0.65, −0.35], ρ p‐tau231 [95%CI] = 0.28[0.10, 0.43]), GFAP was only associated with tangles (ρ GFAP [95%CI] = 0.39[0.17, 0.57]), and p‐tau217 and p‐tau181 were associated with both plaques (ρ p‐tau217 [95%CI] = 0.40[0.21, 0.56], ρ p‐tau181 [95%CI] = 0.36[0.15, 0.50]) and tangles (ρ p‐tau217 [95%CI] = 0.52[0.34, 0.66]; ρ p‐tau181 [95%CI] = 0.36[0.17, 0.52]). A model combining p‐tau217 and the Aβ42/40 ratio showed the highest accuracy for predicting the presence of Alzheimer's disease neuropathological change (ADNC, AUC[95%CI] = 0.89[0.82, 0.96]) and plaque load ( R 2 = 0.55), while p‐tau217 alone was optimal for predicting tangle load ( R 2 = 0.45). Our results suggest that high‐performing assays of plasma p‐tau217 and Aβ42/40 might be an optimal combination to assess Alzheimer's‐related pathology in vivo .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plaque, AmyloidAlzheimer DiseaseHumansAutopsyNeuropathologyBiomarkerstau ProteinsAmyloid beta-Peptides

Stichwörter der Autor:innen

Alzheimer's diseaseco-pathologieshead-to-headneuropathologyp-tau species

Substanzen

Biomarkerstau ProteinsAmyloid beta-Peptides

Autor:innen und Institutionen

  • Clinical Memory Research Unit, Department of Clinical Sciences, Malmö, Lund University, Lund, Sweden.
  • Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, The Netherlands.
  • Amsterdam Neuroscience, Neurodegeneration, Amsterdam, The Netherlands.
  • Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Institute of Psychiatry, Psychology and Neuroscience, Maurice Wohl Institute Clinical Neuroscience Institute, King's College London, London, UK.
  • NIHR Biomedical Research Centre for Mental Health and Biomedical Research Unit for Dementia at South London and Maudsley, NHS Foundation, London, UK.

ORCID-Profile: Gemma Salvadó, Rik Ossenkoppele, Nicholas J Ashton, Niklas Mattsson-Carlgren, Kaj Blennow, Oskar Hansson

Förderung

  • European Research Council
  • NIA NIH HHS
  • AD Strategic Fund and Alzheimer's Association
  • ALF‐agreement
  • Alzheimer Drug Discovery Foundation
  • Alzheimer's Association 2021 Zenith Award
  • Bluefield Project
  • Erling Persson Family Foundation

Zitieren

APA

Salvadó, G., Ossenkoppele, R., Ashton, N. J., Beach, T. G., Serrano, G. E., Reiman, E. M., Zetterberg, H., Mattsson-Carlgren, N., Janelidze, S., Blennow, K., & Hansson, O. (2023). Specific associations between plasma biomarkers and postmortem amyloid plaque and tau tangle loads. EMBO Molecular Medicine, 15(5). https://doi.org/10.15252/emmm.202217123

Vancouver

Salvadó G, Ossenkoppele R, Ashton NJ, Beach TG, Serrano GE, Reiman EM, et al. Specific associations between plasma biomarkers and postmortem amyloid plaque and tau tangle loads. EMBO Molecular Medicine. 2023;15(5). doi:10.15252/emmm.202217123

BibTeX
@article{Salvad2023,
  author = {Salvadó, Gemma and Ossenkoppele, Rik and Ashton, Nicholas J and Beach, Thomas G and Serrano, Geidy E and Reiman, Eric M and Zetterberg, Henrik and Mattsson-Carlgren, Niklas and Janelidze, Shorena and Blennow, Kaj and Hansson, Oskar},
  title = {Specific associations between plasma biomarkers and postmortem amyloid plaque and tau tangle loads},
  journal = {EMBO Molecular Medicine},
  year = {2023},
  volume = {15},
  number = {5},
  doi = {10.15252/emmm.202217123}
}
Kostenlos starten →